ADAR1 Capital Management »

Mei Pharma shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Mei Pharma shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Mei Pharma

Tip: Access up to 7 years of quarterly data

All positions including Mei Pharma held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mei Pharma by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $708k 292k 2.42

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Mei Pharma

Citadel Advisors
Polar Securities
Renaissance Technologies
UBS Group
Vanguard Group
Jain Global
Alyeska Investment Group
Vgi Partners Pty
NewGen Equity Long/Short Fund
Quarry
ADAR1 Capital Management
Ghisallo Capital Management
Susquehanna International
Cantor Fitzgerald, L. P.
Geode Capital Management

View all funds holding Mei Pharma